Company intelligence / Profile preview

Renovo Research

Atlanta, Georgia, United Statesrenovoresearch.com ↗

Ownership: Private
Development stage: Commercial

Overview

Renovo Research is a privately held CRO specializing in identifying new, patentable multi-component crystalline solid forms of APIs to improve physical properties such as solubility and bioavailability. Their expertise enables improved drug product performance and can support patent protection strategies for clients. They do not have their own clinical results or proprietary therapeutic programs but provide enabling technologies to pharma partners.

Modalities: Small moleculeCocrystal-based drug delivery technology
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Renovo Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renovo Research.

Explore the full profile